X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs SANOFI INDIA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD SANOFI INDIA ALEMBIC LTD/
SANOFI INDIA
 
P/E (TTM) x 122.5 33.7 363.1% View Chart
P/BV x 4.6 6.4 70.8% View Chart
Dividend Yield % 0.2 1.4 17.6%  

Financials

 ALEMBIC LTD   SANOFI INDIA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
SANOFI INDIA
Dec-16
ALEMBIC LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs534,560 1.2%   
Low Rs294,400 0.7%   
Sales per share (Unadj.) Rs4.71,028.5 0.5%  
Earnings per share (Unadj.) Rs8.8129.0 6.8%  
Cash flow per share (Unadj.) Rs9.0186.0 4.8%  
Dividends per share (Unadj.) Rs0.1568.00 0.2%  
Dividend yield (eoy) %0.41.5 24.1%  
Book value per share (Unadj.) Rs27.7753.6 3.7%  
Shares outstanding (eoy) m267.0323.03 1,159.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.74.4 199.7%   
Avg P/E ratio x4.734.7 13.5%  
P/CF ratio (eoy) x4.624.1 18.9%  
Price / Book Value ratio x1.55.9 24.9%  
Dividend payout %1.752.7 3.2%   
Avg Mkt Cap Rs m10,962103,174 10.6%   
No. of employees `000NA3.6 0.0%   
Total wages/salary Rs m2383,592 6.6%   
Avg. sales/employee Rs ThNM6,537.7-  
Avg. wages/employee Rs ThNM991.4-  
Avg. net profit/employee Rs ThNM819.8-  
INCOME DATA
Net Sales Rs m1,26023,686 5.3%  
Other income Rs m264708 37.3%   
Total revenues Rs m1,52424,394 6.2%   
Gross profit Rs m835,281 1.6%  
Depreciation Rs m611,313 4.7%   
Interest Rs m015 2.0%   
Profit before tax Rs m2854,661 6.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m61,691 0.4%   
Profit after tax Rs m2,3432,970 78.9%  
Gross profit margin %6.622.3 29.5%  
Effective tax rate %2.136.3 5.9%   
Net profit margin %185.912.5 1,482.5%  
BALANCE SHEET DATA
Current assets Rs m1,68915,673 10.8%   
Current liabilities Rs m4866,678 7.3%   
Net working cap to sales %95.438.0 251.3%  
Current ratio x3.52.3 148.0%  
Inventory Days Days21776 285.5%  
Debtors Days Days8122 363.2%  
Net fixed assets Rs m1,6248,098 20.1%   
Share capital Rs m534230 231.9%   
"Free" reserves Rs m5,96017,088 34.9%   
Net worth Rs m7,40417,356 42.7%   
Long term debt Rs m1040-   
Total assets Rs m8,01025,400 31.5%  
Interest coverage x950.7311.7 305.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.20.9 16.9%   
Return on assets %29.311.8 248.9%  
Return on equity %31.617.1 184.9%  
Return on capital %31.326.9 116.1%  
Exports to sales %2.924.5 12.0%   
Imports to sales %28.928.0 103.1%   
Exports (fob) Rs m375,801 0.6%   
Imports (cif) Rs m3646,627 5.5%   
Fx inflow Rs m377,145 0.5%   
Fx outflow Rs m3656,846 5.3%   
Net fx Rs m-328299 -109.6%   
CASH FLOW
From Operations Rs m3463,226 10.7%  
From Investments Rs m-48-1,555 3.1%  
From Financial Activity Rs m-301-1,818 16.6%  
Net Cashflow Rs m-3-147 2.0%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 0.2 14.4 1.4%  
FIIs % 9.7 14.6 66.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 10.5 248.6%  
Shareholders   54,701 15,184 360.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   J.B.CHEMICALS  VENUS REMEDIES  STERLING BIOTECH  CADILA HEALTHCARE  AUROBINDO PHARMA  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 20, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS